openPR Logo
Press release

Releases New Report on the Lyme Disease Diagnostic Market

02-05-2018 03:42 PM CET | Health & Medicine

Press release from: Transparency Market Research

Releases New Report on the Lyme Disease Diagnostic Market

Lyme disease is an infectious disease caused by bacterial species borrelia. It is a tick borne disease caused by the transmission to humans by the bite of infected ticks. Patients infected with lyme disease suffer from symptoms such as fever, depression, fatigue and skin rashes. If the disease is diagnosed at an early stage then it can be treated with antibiotics. However, if the disease is left untreated then it affects heart, joint and central nervous system and might become a cause for death.

The lyme disease diagnostic market is segmented on the basis of diagnostic tests, emerging diagnostic technologies and end users. Emerging technologies segment comprises of molecular diagnostics, monoclonal antibodies, immunoassays, differential light scattering, liposomes, artificial intelligence, flow cytometry, information technology, diagnostic imaging, gel microdroplets, chromatography and others.

Obtain Report Details @ https://www.transparencymarketresearch.com/lyme-disease-diagnostic.html

The endusers segment of the market includes hospitals, commercial/private labs, public health labs and physicians office. Various forms of laboratory testing for lyme disease are available and among them most widely used are serological test. Among the serological tests most commonly used are ELISA and Western Blot.

Moreover, some laboratories offer tests that include urine antigen tests, lymphocytic transformation test, immunofluorescent staining and PCR tests. New lyme disease diagnostic tests are being developed that are particularly suited for diagnosis of chronic lyme infection using blood sample. These tests overcome the accuracy problems which were encountered in serology based tests.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1658

Globally North America accounts for the largest share of the market owing to the most common tick disease in the U.S. According to the Center for Disease Control and Prevention (CDC) in 2011, 24,364 people were diagnosed with lyme disease in the United States. The European and Asian markets are also expected to emerge in near future owing to increase in patients infected with lyme diseases.

Some of the key players engaged in manufacturing of diagnostic tests include Abbott Laboratories, Affymetrix, Inc., Bio-Rad, Roche Diagnostics among others.

Pre-Book Full Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=1065<ype=S

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Releases New Report on the Lyme Disease Diagnostic Market here

News-ID: 931777 • Views:

More Releases from Transparency Market Research

Electric Wheelchair Market Expanding at 9.2% CAGR Through 2036 - By Control Type / By Drive Configuration / By End-use | U.S. • Germany • China • Japan
Electric Wheelchair Market Expanding at 9.2% CAGR Through 2036 - By Control Type …
The global electric wheelchair market continues to demonstrate strong and sustained growth, fueled by demographic transitions, technological innovation, and expanding healthcare access worldwide. Valued at US$ 5.8 billion in 2025, the market is projected to reach US$ 15.3 billion by 2036, expanding at a compound annual growth rate (CAGR) of 9.2% from 2026 to 2036. Discover essential conclusions and data from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4198 This robust trajectory reflects rising
Vehicle Predictive Maintenance Market Size Forecast to USD 13.7 Billion by 2036 with a Focus on AI-Driven Fleet Optimization - Analysis by Transparency Market Research
Vehicle Predictive Maintenance Market Size Forecast to USD 13.7 Billion by 2036 …
Vehicle Predictive Maintenance Market Outlook 2036 The global vehicle predictive maintenance market was valued at USD 3 Billion in 2025 and is projected to reach USD 13.7 Billion by 2036, expanding at a robust CAGR of 14.7% from 2026 to 2036. Market growth is driven by increasing adoption of connected vehicles, rising fleet digitalization, advancements in AI-driven analytics, and growing emphasis on minimizing vehicle downtime and maintenance costs. 👉 Get your sample
Global Air Purification Systems Market to Reach USD 44.3 Billion by 2036 at 7.9% CAGR Driven by Regulatory Mandates, Smart Building Integration, and Rising Health Risks
Global Air Purification Systems Market to Reach USD 44.3 Billion by 2036 at 7.9% …
The global Air Purification Systems Market was valued at US$ 19.2 Bn in 2025 and is projected to expand to US$ 44.3 Bn by 2036, registering a compound annual growth rate (CAGR) of 7.9% from 2026 to 2036. The market's upward trajectory reflects the structural shift in indoor air quality (IAQ) management, moving from discretionary consumer spending to mission-critical infrastructure investment. With historical data available from 2021 to 2024, the industry
Polyvinylpyrrolidone (PVP) Market to Reach USD 6.2 Billion by 2036 Driven by Pharmaceutical and Cosmetic Demand
Polyvinylpyrrolidone (PVP) Market to Reach USD 6.2 Billion by 2036 Driven by Pha …
The Polyvinylpyrrolidone (PVP) Market was valued at around US$ 3.2 billion in 2025 and is projected to reach approximately US$ 6.2 billion by 2036, expanding at a steady CAGR of about 6.0% during the forecast period. This growth is primarily driven by rising demand from the pharmaceutical industry, where PVP is widely used as a tablet binder, solubilizer, and stabilizer, along with increasing consumption in cosmetics and personal care products

All 5 Releases


More Releases for Lyme

Lyme Disease Diagnostics Market Projected to Show Strong Growth
Advance Market Analytics published a new research publication on "Lyme Disease Diagnostics Market Insights, to 2033" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Lyme Disease Diagnostics market was mainly driven by the increasing R&D spending across the world. Get Free Exclusive PDF Sample
Lyme Disease - Drug Pipeline Landscape, 2022
Lyme disease is a tick-borne infection caused by four main species of bacteria Borrelia burgdorferi, Borrelia mayonii, Borrelia afzelii and Borrelia garinii. The disease is characterized by skin rash. Early signs and symptoms of Lyme disease include rash and other symptoms like fever, chills, fatigue, body aches, and swollen lymph nodes. Later symptoms include erythema migrans, joint pain and other neurological problems. To know more about Lyme Disease - Drug Pipeline ,
Lyme Disease - Drug Pipeline Landscape, 2022 | Global Insight Services
Lyme disease is a tick-borne infection caused by four main species of bacteria Borrelia burgdorferi, Borrelia mayonii, Borrelia afzelii and Borrelia garinii. The disease is characterized by skin rash. Early signs and symptoms of Lyme disease include rash and other symptoms like fever, chills, fatigue, body aches, and swollen lymph nodes. Later symptoms include erythema migrans, joint pain and other neurological problems. Diagnosis of Lyme disease involves lab tests to
Lyme Disease Vaccines - Are They Effective?| Valneva, GlaxoSmithKline Plc.
There is currently no Lyme disease vaccine available. LYMERix®, the only vaccine previously marketed in the United States, was withdrawn from the market in 2002 due to a lack of consumer demand. The vaccine's effectiveness deteriorates over time. Lyme Disease Vaccines Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing
Lyme Disease Therapeutics Market Size Statistics, Facts and Figures
Global Lyme Disease Therapeutics Market: Overview Lyme disease is a contagious disease caused by a bacterium species called Borrelia burgdorferi. It is a tick-borne disease caused by transmission of bacteria to humans through the bite of infected ticks. Common indications of Lyme disease include flu-like symptoms, depression, fatigue, and expanding, circular, reddish skin rashes. View Report : https://www.transparencymarketresearch.com/lyme-disease-therapeutics-market.html If left untreated, these symptoms may worsen and can lead to partial or complete
Lyme Disease Diagnostic Testing Market
The report presents a detailed analysis of the Lyme disease diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Lyme disease definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs